T

Terns Pharmaceuticals
D

TERN

3.80000
USD
0.12
(3.26%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-4
حجم السوق
331,883,644
أصول ذات صلة
N
NIO
0.08000
(2.34%)
3.50000 USD
RIVN
RIVN
0.155
(1.14%)
13.800 USD
XPEV
XPEV
0.695
(3.63%)
19.850 USD
المزيد
الأخبار المقالات

العنوان: Terns Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.